CSIMarket
 
Mckesson Corporation  (MCK)
Other Ticker:  
 
 
Price: $495.0900 $11.42 2.361%
Day's High: $495.99 Week Perf: 1.29 %
Day's Low: $ 486.77 30 Day Perf: -2.81 %
Volume (M): 772 52 Wk High: $ 637.51
Volume (M$): $ 382,011 52 Wk Avg: $520.18
Open: $490.64 52 Wk Low: $431.35



 Market Capitalization (Millions $) 64,708
 Shares Outstanding (Millions) 131
 Employees 51,000
 Revenues (TTM) (Millions $) 313,751
 Net Income (TTM) (Millions $) 3,123
 Cash Flow (TTM) (Millions $) -333
 Capital Exp. (TTM) (Millions $) 730

Mckesson Corporation
McKesson Corporation, is a Fortune 16 corporation providing supply, information and care management products and services designed to reduce costs and improve quality across the healthcare industry.

We conduct our business through three segments. Through our Pharmaceutical Solutions segment, we are a leading distributor of ethical and proprietary drugs, and health and beauty care products throughout North America. This segment also manufactures and sells automated pharmaceutical dispensing systems for hospitals and retail pharmacies, medical management and specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, patient and payor services, consulting and outsourcing services to pharmacies and distribution of first-aid products in the United States. Our Medical-Surgical Solutions segment distributes medical-surgical supplies and equipment, and provides logistics and related services within the United States. Our Information Solutions segment delivers enterprise-wide patient care, clinical, financial, supply chain, managed care and strategic management software solutions, as well as outsourcing and other services, to healthcare organizations throughout North America, the United Kingdom and other European countries. The Company's strategy is to create strong, value-based relationships with customers, enabling us to sell additional products and services to these customers over time.

The U.S. Pharmaceutical Distribution business operates and serves over 30,000 locations through a network of 28 distribution centers, as well as a master distribution center and a repackaging facility, serving all 50 states. We invest in technology and other systems at all of our distribution centers to enhance safety, reliability and the best product availability for our customers. For example, in all of our distribution centers we use Acumax' Plus, a Smithsonian award-winning technology, which integrates and tracks all internal functions, such as receiving, put-away and order fulfillment. Acumax' Plus uses bar code technology, wrist-mounted computer hardware, and radio frequency signals to provide our customers with industry leading order quality and fulfillment at up to 99.9% accuracy. Closed Loop DistributionSM, which integrates portable Palm technology with Acumax' Plus to give customers complete ordering and inventory control, and Supply Management OnlineSM, an Internet-based ordering, purchasing, third-party reconciliation and account management system, help ensure that our customers have the right products at the right time for their facilities and patients.

Competition

In every area of healthcare distribution operations, our Pharmaceutical Solutions and Medical-Surgical Solutions segments face strong competition, both in price and service, from national, regional and local full-line, short-line and specialty wholesalers, service merchandisers, self-warehousing chains, and manufacturers engaged in direct distribution. In addition, these segments face competition from various other service providers and from pharmaceutical and other healthcare manufacturers (as well as other potential customers of the segments) which may from time to time decide to develop, for their own internal needs, supply management capabilities which are provided by the segments and other competing service providers. Price, quality of service, and, in some cases, convenience to the customer are generally the principal competitive elements in these segments.

Our Information Solutions segment experiences substantial competition from many firms, including other computer services firms, consulting firms, shared service vendors, certain hospitals and hospital groups, hardware vendors and Internet-based companies with technology applicable to the healthcare industry. Competition varies in size from small to large companies, in geographical coverage, and in scope and breadth of products and services offered.



   Company Address: 6555 State Hwy 161 Irving 75039 TX
   Company Phone Number: 446-4800   Stock Exchange / Ticker: NYSE MCK


Customers Net Income grew by MCK's Customers Net Profit Margin grew to

10.02 %

2.15 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CAH        2.19% 
CVS        5.88% 
WBA        4.37% 
CTSH   -0.82%    
DHR   -1.86%    
JNJ   -0.92%    
• View Complete Report
   



Business Update

Strategic Shift McKesson Corporation Divests Rexall and Well.ca in Pursuit of Oncology Excellence,

Published Thu, Sep 5 2024 11:09 AM UTC

' CSIMarket.com ' 'A Transaction of Distinction: McKesson Corporation Sells Rexall and Well.ca to Birch Hill Equity Partners'In the grand theater of American commerce, we find ourselves witnessing a significant and strategic realignment as McKesson Corporation, that venerable institution of the healthcare domain, announces the divestiture of its Canadian enterprises, Rexall...

Business Update

McKesson Enters New Frontier Acquisition of Florida Cancer Specialists Signals Growth Strategy in Oncology Sector

Published Tue, Aug 27 2024 1:16 AM UTC

In a strategic move to enhance its presence in the oncology sector, McKesson Corporation has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures). This venture represents an important collaboration with Florida Cancer Specialists & Research Institute, LLC (FCS), a renowned physician-owne...

Business Update

McKesson Corp Moves to Strengthen Oncology Services through Strategic Acquisition

Published Mon, Aug 26 2024 3:09 PM UTC

In a significant strategic maneuver aimed at bolstering its presence in the oncology sector, McKesson Corporation (NYSE: MCK) has announced a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures). This move is set against the backdrop of evolving dynamics within the healthcare landscape, particula...

Dividend

McKesson's Confidence Soars: 15% Dividend Hike Fuels Stock Surge to New Highs!

Published Thu, Aug 1 2024 2:57 PM UTC

McKesson Corporation?s Strong Dividend Growth Signals Confidence and Market Resilience
In a decisive move that speaks volumes about its financial health and strategic outlook, McKesson Corporation (NYSE: MCK) has announced a 15% increase in its quarterly dividend, raising the payout from $0.62 to $0.71 per share. The Board of Directors declared this new dividend, which ...

Stocks on the Move

McKesson Corporation Navigating Challenges and Driving Growth in the Midst of Industry Turmoil

Published Fri, Jun 28 2024 6:14 AM UTC

McKesson Corporation, a leading healthcare services and pharmaceutical distribution company, has been facing a series of events that have impacted its performance in recent months. This article will examine the key events and their implications on McKesson's performance, as well as provide an analysis of the company's place in the retail sector. Despite the challenges it has...







Mckesson's Segments
United States    93.41 % of total Revenue
International    6.59 % of total Revenue
Pharmaceutical Solutions    91.29 % of total Revenue
Medical-Surgical Solutions    6.47 % of total Revenue
Total Provider Technologies    2.24 % of total Revenue
Pharmaceutical Solutions    229.07 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com